🔗 Visit the ClinicalTrials.gov page for NCT00831792
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Novel therapies for metastatic castrate-resistant prostate cancer. | J Natl Cancer Inst | 2011 | 1.98 |
| 2 | Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases. | Sci Transl Med | 2014 | 1.71 |
| 3 | Therapeutic targeting of the prostate cancer microenvironment. | Nat Rev Urol | 2010 | 1.22 |
| 4 | Molecular pathways and targets in prostate cancer. | Oncotarget | 2014 | 1.00 |
| 5 | Targeting fibroblast growth factor pathways in prostate cancer. | Clin Cancer Res | 2013 | 0.98 |
| 6 | Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer. | Future Med Chem | 2012 | 0.87 |